Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Bröker

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
Arzneimittel-Forschung|January 22, 2004
Development of new vaccines against meningococcal diseaseMichael Bröker
Japanese Journal of Infectious Diseases|March 24, 2009
Burden of invasive disease caused by Haemophilus influenzae type b in AsiaMichael Bröker
Human Vaccines & Immunotherapeutics|September 2, 2015
Potential protective immunogenicity of tetanus toxoid, diphtheria toxoid and Cross Reacting Material 197 (CRM197) when used as carrier proteins in glycoconjugatesMichael Bröker
Human Vaccines|July 26, 2011
Indirect effects by meningococcal vaccines: herd protection versus herd immunityMichael Bröker
Travel Medicine and Infectious Disease|February 13, 2007
New foci of tick-borne encephalitis virus in Europe: consequences for travellers from abroadMichael Bröker, Dieter Gniel
Expert Review of Vaccines|October 14, 2005
Tick-borne encephalitis vaccines: past and presentOlaf Zent, Michael Bröker
Vaccine|January 22, 2008
After a tick bite in a tick-borne encephalitis virus endemic area: current positions about post-exposure treatmentMichael Bröker, Herwig Kollaritsch
Expert Review of Vaccines|September 23, 2006
Are tick-borne encephalitis vaccines interchangeable?Michael Bröker, Ines Schöndorf
Travel Medicine and Infectious Disease|March 2, 2010
Quadrivalent meningococcal vaccines: hyporesponsiveness as an important consideration when choosing between the use of conjugate vaccine or polysaccharide vaccineMichael Bröker, Keith Veitch
Vector Borne and Zoonotic Diseases (Larchmont, N.Y.)|October 8, 2008
Tick-borne encephalitis in mainland ChinaZhi Lu, Michael Bröker, Guodong Liang
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Arzneimittel-Forschung|January 22, 2004
Development of new vaccines against meningococcal diseaseMichael Bröker
Japanese Journal of Infectious Diseases|March 24, 2009
Burden of invasive disease caused by Haemophilus influenzae type b in AsiaMichael Bröker
Human Vaccines & Immunotherapeutics|September 2, 2015
Potential protective immunogenicity of tetanus toxoid, diphtheria toxoid and Cross Reacting Material 197 (CRM197) when used as carrier proteins in glycoconjugatesMichael Bröker
Human Vaccines|July 26, 2011
Indirect effects by meningococcal vaccines: herd protection versus herd immunityMichael Bröker
Travel Medicine and Infectious Disease|February 13, 2007
New foci of tick-borne encephalitis virus in Europe: consequences for travellers from abroadMichael Bröker, Dieter Gniel
Expert Review of Vaccines|October 14, 2005
Tick-borne encephalitis vaccines: past and presentOlaf Zent, Michael Bröker
Vaccine|January 22, 2008
After a tick bite in a tick-borne encephalitis virus endemic area: current positions about post-exposure treatmentMichael Bröker, Herwig Kollaritsch
Expert Review of Vaccines|September 23, 2006
Are tick-borne encephalitis vaccines interchangeable?Michael Bröker, Ines Schöndorf
Travel Medicine and Infectious Disease|March 2, 2010
Quadrivalent meningococcal vaccines: hyporesponsiveness as an important consideration when choosing between the use of conjugate vaccine or polysaccharide vaccineMichael Bröker, Keith Veitch
Vector Borne and Zoonotic Diseases (Larchmont, N.Y.)|October 8, 2008
Tick-borne encephalitis in mainland ChinaZhi Lu, Michael Bröker, Guodong Liang
Pageof 4